chartexchange

Entera Announces Third Quarter 2026 Financial Results and Business Updates

GlobeNewswire Inc. | Nov 6, 2026 4:15 PM EST

Clinical Preparations Advanced for EB613 Phase 3 Osteoporosis Study, with First Site Activation Expected in Late 2026

Read original article